CVE detail

CVE-2019-15931 — CVE-2019-15931

Published 2019-12-12 · Modified 2026-06-17 · Vendor intesync · Product solismed · Source nvd

CRITICAL

severity

CVSS-derived band

9.8

CVSS v3

0–10 scale

0.0272

EPSS probability

exploitation probability, 30d

85.0%

EPSS percentile

percentile vs all CVEs

NOT LISTED

CISA KEV

known exploited catalog

Description

Intesync Solismed 3.3sp allows Directory Traversal, a different vulnerability than CVE-2019-16246.

Remediation

No vendor-published fix data in our corpus for this CVE. Check the references below or the vendor's PSIRT / security advisories page.

References

NVD entry ↗
CVE.org record ↗

cvedb.io · NVD · CISA KEV · FIRST EPSS · vendor advisories (CVE Program List v5). Informational only, no warranty — verify every remediation against the vendor advisory before acting on it. This product uses data from the NVD API but is not endorsed or certified by the NVD, CISA, FIRST.org or any vendor named. CVE® is a registered trademark of The MITRE Corporation.